A Review On Huntington Protein: Insight Into Protein Aggregation and Therapeutic Interventions
Authors:
- 1 April 2022
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Drug Metabolism
- Vol. 23 (4) , 260-282
Abstract
Huntington's disease (HD) is a distressing, innate neurodegenerative disease that descends from CAG repeat expansion in the huntingtin gene causing behavioral changes, motor dysfunction, and dementia in children and adults. Mutation in huntingtin (HTT) protein has been suggested to cause neuron loss in the cortex and striatum through various mechanisms, including abnormal regulation of transcription, proteasomal dysfunction, posttranslational modification, and other events regulating toxicity. Pathogenesis of HD involves cleavage of the huntingtin protein followed by the neuronal accumulation of its aggregated form. Several research groups made possible efforts to reduce huntingtin gene expression, protein accumulation, and protein aggregation using inhibitors and molecular chaperones as developing drugs against HD. Herein, we review the mechanism proposed towards the formation of HTT protein aggregation and the impact of therapeutic strategies for the treatment of HD.Keywords
This publication has 175 references indexed in Scilit:
- In-vitro evaluation of selected Egyptian traditional herbal medicines for treatment of alzheimer diseaseBMC Complementary and Alternative Medicine, 2013
- Neurodegenerative processes in Huntington's diseaseCell Death & Disease, 2011
- Cognitive Impairment in Huntington Disease: Diagnosis and TreatmentCurrent Neurology and Neuroscience Reports, 2011
- Preferential accumulation of N-terminal mutant huntingtin in the nuclei of striatal neurons is regulated by phosphorylationHuman Molecular Genetics, 2011
- Hsp70 and Hsp40 Functionally Interact with Soluble Mutant Huntingtin Oligomers in a Classic ATP-dependent Reaction CycleJournal of Biological Chemistry, 2010
- ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's diseaseHuman Molecular Genetics, 2010
- CAG‐repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approachesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- EXPRESSION OF CONCERN: Ginsenosides protect striatal neurons in a cellular model of Huntington's diseaseJournal of Neuroscience Research, 2009
- Psychiatric disorders in preclinical Huntington's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2007